or Try an Advanced Search...

    Technical Analysis for NXL - Nexalin Technology, Inc.

    Grade Last Price % Change Price Change
    D 1.21 -6.92% -0.09
    NXL closed down 6.92 percent on Wednesday, May 8, 2024, on 4 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical NXL trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    MACD Bearish Centerline Cross Bearish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Doji - Bullish? Reversal -6.92%
    Wide Bands Range Expansion -6.92%
    Older End-of-Day Signals for NXL ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 4 hours ago
    Possible NR7 about 4 hours ago
    60 Minute Opening Range Breakdown about 4 hours ago
    Down 3% about 8 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NXL Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Neuroscience Alzheimer's Disease Mental Health Chronic Pain Dementia Psychiatric Diagnosis Psychiatry Insomnia Mental Disorder Neurostimulation Mental Health Disorders

    Is NXL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Nexalin Technology regains compliance with Nasdaq continued listing requirements
    Apr 25 Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
    Apr 16 Nexalin Technology files to offer common stock worth $5.65M
    Apr 10 Nexalin Technology CEO Provides Letter to Shareholders
    Apr 9 Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing
    Apr 4 Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
    Apr 4 Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device
    Apr 2 Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 2 Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
    Mar 30 Nexalin Technology Full Year 2023 Earnings: US$0.63 loss per share (vs US$0.30 loss in FY 2022)
    See more NXL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.4
    52 Week Low 0.2528
    Average Volume 1,025,954
    200-Day Moving Average 0.63
    50-Day Moving Average 1.23
    20-Day Moving Average 1.58
    10-Day Moving Average 1.46
    Average True Range 0.28
    RSI (14) 42.20
    ADX 23.16
    +DI 21.67
    -DI 26.91
    Chandelier Exit (Long, 3 ATRs) 2.05
    Chandelier Exit (Short, 3 ATRs) 1.63
    Upper Bollinger Bands 2.21
    Lower Bollinger Band 0.96
    Percent B (%b) 0.2
    BandWidth 78.56
    MACD Line -0.02
    MACD Signal Line 0.06
    MACD Histogram -0.0743
    Fundamentals Value
    Market Cap 8.82 Million
    Num Shares 7.29 Million
    EPS -0.64
    Price-to-Earnings (P/E) Ratio -1.89
    Price-to-Sales 17.28
    Price-to-Book 0.68
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.34
    Resistance 3 (R3) 1.36 1.33 1.32
    Resistance 2 (R2) 1.33 1.29 1.32 1.31
    Resistance 1 (R1) 1.27 1.27 1.25 1.25 1.30
    Pivot Point 1.24 1.24 1.23 1.23 1.24
    Support 1 (S1) 1.18 1.21 1.17 1.17 1.12
    Support 2 (S2) 1.15 1.19 1.14 1.11
    Support 3 (S3) 1.09 1.15 1.10
    Support 4 (S4) 1.08